Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:14:05 EDT Tue 29 Apr 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

C:BNXT - BioNxt Solutions Inc. - https://bionxt.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BNXT - C  0.60.445·0.453.50.45120.352790.46  0.47  0.440.69  0.1715:58:13Apr 2315 min RT 2¢
CSE - C0.60.445·0.453.50.44-0.01-2.280.135360.46  0.46  0.440.69  0.1715:48:3015 min
NEO ATS - U 0.454.5240.445  0.45  0.4415:58:1315 min
Omega - O 0.44-0.01-2.24.5260.45  0.47  0.4415:48:3015 min
CX2 - H 0.44-0.01-2.220.08160.455  0.46  0.4415:41:1715 min
CXD - D 0.46+0.012.23.4160.46  0.46  0.4612:14:1015 min
TriAct - M 0.457.8311    15 min

Recent Trades - Last 10 of 79
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59M0.45 43414 Virtu ITG2 RBCE
15:58:13M0.45 501 Anonymous2 RBCE
15:58:13U0.45 5002 RBC2 RBCK
15:48:30O0.44-0.015001 Anonymous1 AnonymousK
15:48:30C0.44-0.012,5001 Anonymous1 AnonymousK
15:41:17H0.44-0.012,0001 Anonymous1 AnonymousK
15:41:17C0.44-0.011,0001 Anonymous1 AnonymousK
15:24:48H0.44-0.011,0001 Anonymous1 AnonymousK
15:24:48U0.44-0.013,0001 Anonymous1 AnonymousK
15:24:47H0.445-0.0051,5007 TD Sec1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-04-23 09:51C:BNXT0.435News ReleaseBionxt prepares for MS human bioequivalence study
2025-03-14 19:13C:BNXT0.57News ReleaseBionxt closes $900,000 final tranche of placement
2025-02-28 19:46C:BNXT0.51News ReleaseBionxt closes first tranche of debenture unit financing
2025-02-24 18:09C:BNXT0.50News ReleaseBionxt arranges $2.5-million debenture unit financing
2025-02-21 19:52C:BNXT0.50News ReleaseBionxt clarifies promotional activity by Apaton, Cayo
2025-02-19 09:03C:BNXT0.50News ReleaseBionxt completes patent filings, bioequivalence study
2025-01-31 20:56C:BNXT0.41News ReleaseBionxt appoints Waterhouse as director
2025-01-21 11:01C:BNXT0.41News ReleaseBionxt Solutions moves R&D work to Gen-Plus CRDO
2025-01-14 19:56C:BNXT0.41News ReleaseBionxt closes $890,000 final tranche of placement
2025-01-09 02:39C:BNXT0.39News ReleaseBionxt extends 8% debenture by one year
2024-12-20 20:36C:BNXT0.31News ReleaseBionxt closes $1.4-million third tranche of placement
2024-12-19 09:51C:BNXT0.315News ReleaseBionxt files int'l patents for sublingual delivery
2024-12-09 09:53C:BNXT0.29News ReleaseBionxt talks progress on cladribine thin film
2024-12-02 10:33C:BNXT0.28News ReleaseBionxt developing sublingual thin film for semaglutide
2024-11-29 19:42C:BNXT0.28News ReleaseBionxt closes second tranche of debenture financing
2024-11-29 13:50C:BNXT0.25SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-29 13:44C:BNXT0.25SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-25 10:08C:BNXT0.26News ReleaseBionxt Solutions talks product development plans
2024-11-12 19:43C:BNXT0.25News ReleaseBionxt closes $425,000 first tranche of placement
2024-10-29 11:58C:BNXT0.25News ReleaseBionxt Solutions begins national patent filings